Skip to main content

Spectral Medical Inc(EDT-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Spectral Medical Inc down on Tuesday (EDT)

Automated Summaries - The Globe and Mail - Tue Apr 16, 4:02PM CDT

Today during trading, shares of Spectral Medical Inc opened at $0.46 and closed at $0.45. Intraday prices ranged from a low of $0.45 to a high of $0.47.

Share prices dipped -3.26 percent from the previous day's close of $0.46.

Today across North America, the TSX Composite closed -0.73% at 21740.20, the S&P 500 closed -1.20% at 5061.82, the Dow Jones Industrial Average closed -0.65% at 37735.11 and the Nasdaq Composite closed -1.79% at 15885.02.

Spectral Medical Inc traded under EDT on the Toronto Stock Exchange (TSX).

A total of 18,523 shares was traded during the last trading day, with total trades of 13, while having an average volume of 17,470 over the last 5-days.

Trading across the entire TSX saw 1,840 price advancers against 3,375 declines and 112 unchanged.

During the prior 52 weeks, EDT.TO has traded as high as $0.67 (February 07,2024) and low as $0.23 (June 14,2023). Moreover, in the last 12 months, Spectral Medical Inc's shares have soared 56.14 percent, while this year, they have advanced 4.71%.

It announced a 0.12 dividend on November 29/11, with an December 19/11 ex-date and January 20/12 pay day.

Following today's trading, Spectral Medical Inc has a market capitalization of $128.15 million on a float of 278,576 shares outstanding. Its annual EPS is $-0.06.

Spectral Medical Inc is a None company headquartered in Toronto, CAN.

Currently, Spectral Medical Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe